Topic
Transurethral Resection of Bladder Tumor (TURBT)
23 Podcasts • 3 Courses on BackTable
Hear how experienced physicians approach Transurethral Resection of Bladder Tumor (TURBT) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 323 • 11 Aug 2026
Managing Intermediate-Risk Bladder Cancer
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common, progression is uncommon, and the burden of repeated procedures can add up quickly. On this episode of the BackTable Urology Podcast, Dr. Ruchika Talwar interviews Dr. Charles "Chas" Peyton about how to manage intermediate-risk bladder cancer patients while balancing disease control and quality of life. They discuss the cumulative impact of repeated TURBTs and explore the evolving role of office-based treatments and chemoablative therapies as alternatives to the traditional treatment cycle.
More on Transurethral Resection of Bladder Tumor (TURBT)
Loading recent podcasts…
Urology # 323
Aug 10, 2026
with Dr. Charles Peyton, Dr. Ruchika Talwar
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common,...
1,300+ listens
Urology # 310
Jun 17, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
1,200+ listens
Tumor Board # 65
Jun 10, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
Urology # 266
Oct 16, 2025
with Dr. Sima Porten, Dr. Patrick Hensley, Dr. Vignesh Packiam
When a patient is diagnosed with non-muscle invasive bladder cancer (NMIBC), how do you tailor the conversation and...
1,100+ listens
Tumor Board # 67
Jun 17, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
Urology # 308
Jun 10, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
1,000+ listens
Urology # 275
Nov 20, 2025
with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam
When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern...
1,400+ listens
Tumor Board # 30
Oct 7, 2025
with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam
When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern...
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.